cancer genetics PhD Projects, Programs & Scholarships

We have 59 cancer genetics PhD Projects, Programs & Scholarships

Keywords:"cancer" AND "genetics" ×
Discipline:
Subject:
Country:
Location:
Institution:
Department:
Course:
Show:
Show:
clear all

Order by

Showing 1 to 10 of 59 PhDs

Control of tissue growth and cancer by the Hippo pathway

Peter MacCallum Cancer Centre
Sir Peter MacCallum Department of Oncology, University of Melbourne

Dr K. Harvey, Dr C Poon

Applications accepted all year round

A new frontier in biomedical research will involve watching individual proteins work in real time, in living organs. Traditionally, researchers have drawn conclusions about gene function using indirect techniques that only allow us to infer what a gene normally does, without actually watching it work.

Details

PhD Research Project Type/Funding

PhD studentship in oncolytic virotherapy and cancer immunology: Establishing a potent immuno-oncolytic virotherapy for colorectal cancer.

Cardiff University
Cardiff School of Medicine

Dr A Parker, Prof A Gallimore, Dr A Godkin

Application Deadline: 1 February 2019

An exciting, fully funded PhD studentship opportunity. working at the interface between oncolytic virotherapy and cancer immunotherapy to develop a refined, tumour targeted “immunovirotherapy” suitable for colorectal cancer treatment.

Details

PhD Research Project Type/Funding

How does amino acid metabolism affect tumour growth?

Peter MacCallum Cancer Centre
Sir Peter MacCallum Department of Oncology, University of Melbourne

Dr L. Cheng

Applications accepted all year round

The effect of diet on tumour growth is hotly debated but poorly characterized. Due to the heterogeneous nature of the tumours, dietary studies in patients with varied genetic background often led to inconclusive outcome.

Details

PhD Research Project Type/Funding

Wellcome Trust 4-year Doctoral Programme in Genomic Medicine and Statistics

University of Oxford
Medical Sciences Doctoral Training Centre

Wellcome Trust 4-year Doctoral Programme in Genomic Medicine and Statistics. Genomic technologies have transformed biomedical research over the last decade and are now having significant impact on the practice of clinical medicine.

Details

4 Year PhD Programme Type/Funding

Regulation and function of cytotoxic lymphocytes

Peter MacCallum Cancer Centre
Sir Peter MacCallum Department of Oncology, University of Melbourne

Dr I. Voskoboinik, Prof J.A. Trapani

Applications accepted all year round

Cytotoxic lymphocytes recognize and kill cancerous and virus-infected cells through cytotoxic granule exocytosis pathway. Cytotoxic granules store a pore-forming protein, perforin, and serine proteases, granzymes.

Details

PhD Research Project Type/Funding

Molecular mechanisms regulating the developmental plasticity of pancreatic cancer cells

University of Oxford
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences

Dr S Pauklin

Application Deadline: 11 January 2019

NDORMS 2019/9. Pancreatic cancers are among the most lethal malignancies in human due to highly metastatic characteristics and the poor responsiveness to currently used cancer therapeutics.

Details

PhD Research Project Type/Funding

DNA Damage and Repair: Studying DNA damage and repair to understand the causes of cancer and improve its treatment

University of Oxford
Radcliffe Department of Medicine

Prof P McHugh, Prof J Rehwinkel, Prof A Harris

Application Deadline: 11 January 2019

Our DNA is constantly under threat from damaging agents. If unrepaired this DNA damage can lead to errors during genome duplication, including the mutations that can lead to cancer and other human diseases.

Details

PhD Research Project Type/Funding

MRC Precision Medicine DTP: Molecular pathology data science studies of breast cancer

University of Edinburgh
College of Medicine and Veterinary Medicine

Dr J Figueroa, Dr A Sims, Assoc Prof N Tobin

Application Deadline: 7 January 2019

BACKGROUND. Datasets linked to molecular phenotypes are desperately needed to provide academia and industry the real-world evidence needed for discovery, validation and implementation of new biomarkers for improved cancer outcomes.

Details